Hematopoietic Stem Cell Transplantation in the PICU

作者: Shilpa K. Shah , Sonata Jodele , Stella M. Davies , Ranjit S. Chima

DOI: 10.1007/978-1-4471-6416-6_27

关键词:

摘要: Hematopoietic stem cell transplantation (SCT) is a therapeutic option for patients with bone marrow failure, certain malignancies and inborn errors of metabolism. Complications requiring intensive care are frequent, intensivists need to be familiar the process disorders that unique these patients. The transplant involves use high dose chemotherapy or radiation, followed by intravenous infusion cells matched recipient at human leukocyte antigen (HLA) loci. Full recovery normal immune system can take year more, so following transplantation, exquisitely susceptible infections. Moreover, complications such as graft versus host disease, idiopathic pneumonia syndrome, sinusoidal obstruction syndrome associated thrombotic microangiopathy common in first hundred days after infusion. Respiratory failure presentation necessitating admission may due infectious non-infectious causes. Mechanical ventilation needed along broad spectrum anti-microbial coverage; corticosteroids commonly used if disease present. Acute most frequent children receiving grafts from unrelated donors results significant morbidity. Increased immunosuppression cornerstone therapy protection infection essential survival. Sinusoidal lead multiple organ limited options, but both resolve good supportive during period failure. Outcomes who develop SCT remain poor despite aggressive care, however, single do well. Integrated multi-disciplinary between physicians, other specialists nephrologists pulmonologists leads improved outcomes.

参考文章(241)
C Lenarsky, K Weinberg, D Kohn, R Parkman, M F Ozkaynak, L Sender, Hepatic veno-occlusive disease post-bone marrow transplantation in children conditioned with busulfan and cyclophosphamide: incidence, risk factors, and clinical outcome. Bone Marrow Transplantation. ,vol. 7, pp. 467- 474 ,(1991)
Scott Metcalfe, Alistair Woodward, Alexandra Macmillan, M Baker, P Howden-Chapman, G Lindsay, S Hales, D Sinclair, R Jaine, L Springford, A Holmes, G Laking, R Jones, H Carr, R Edwards, C Shaw, S Wells, J Hosking, A Forde, M Bismark, S Palmer, G Keating, J Simpson, R Highton, D Dhar, P Kane, Zealand Climate New, Why New Zealand must rapidly halve its greenhouse gas emissions The New Zealand Medical Journal. ,vol. 122, pp. 72- 95 ,(2009)
Kenneth R. Cooke, Werner Krenger, Geoff Hill, Thomas R. Martin, Lester Kobzik, Joanne Brewer, Raymond Simmons, James M. Crawford, Marcel R.M. van den Brink, James L.M. Ferrara, Host Reactive Donor T Cells Are Associated With Lung Injury After Experimental Allogeneic Bone Marrow Transplantation Blood. ,vol. 92, pp. 2571- 2580 ,(1998) , 10.1182/BLOOD.V92.7.2571
Cecilia M. Choi, Alvin H. Schmaier, Michael R. Snell, Hillard M. Lazarus, Thrombotic Microangiopathy in Haematopoietic Stem Cell Transplantation Drugs. ,vol. 69, pp. 183- 198 ,(2009) , 10.2165/00003495-200969020-00004
S I Bearman, G L Anderson, M Mori, M S Hinds, H M Shulman, G B McDonald, Venoocclusive disease of the liver: development of a model for predicting fatal outcome after marrow transplantation. Journal of Clinical Oncology. ,vol. 11, pp. 1729- 1736 ,(1993) , 10.1200/JCO.1993.11.9.1729
Eileen Merriman, Mark Smith, Helen Marr, Hilda Mangos, Peter Ganly, Catherine Stoddart, Emma-Jane McDonald, Successful treatment of transplant-associated microangiopathy with rituximab. The New Zealand Medical Journal. ,vol. 122, pp. 72- ,(2009)